ArticleCureus2025
Effects of Gestational Diabetes Mellitus on Maternal and Neonatal Outcomes: A Prospective Cohort Study in Northern Sri Lanka.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effects of diabetes mellitus during pregnancy on pregnancy outcomes and growth and development of children aged 0-6 years: a retrospective cohort study.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionGestational diabetes mellitus (GDM) has emerged as a significant global public health concern due to its association with adverse maternal and neonatal outcomes. The aim of the study was to assess the effects of GDM on maternal and neonatal outcomes.
methodsA prospective cohort study was conducted among 216 pregnant women diagnosed with GDM who were receiving care at Teaching Hospital Jaffna. Women with pre-existing diabetes were excluded from the study. Participants were followed from the time of GDM diagnosis until six weeks postpartum. Data were collected using structured questionnaires and a review of clinical records. Descriptive statistics were used to summarize the demographic and clinical characteristics. The chi-square test was used to assess the association between blood glucose control and adverse maternal and neonatal outcomes. A p-value ≤0.05 was considered statistically significant.
resultsThe majority of participants (61.1%; n = 132) were aged 35 years or older. More than two-thirds of the participants (67.6%; n=146) were obese. The majority were multiparous (62%; n = 134), and GDM was diagnosed during the second trimester of pregnancy (61.1%; n = 132). A total of 17 mothers (7.9%) experienced a miscarriage during the current pregnancy. Maternal and neonatal complications were reported in 60 (27.8%) and 29 (14.6%) cases, respectively. A significant association was found between blood glucose control and both maternal (p < 0.001) and neonatal complications (p = 0.007).
conclusionDespite the provision of multidisciplinary antenatal care for diabetes, women with GDM remain at increased risk for maternal and neonatal complications. Greater emphasis is required on targeting modifiable risk factors, particularly by enhancing adherence to diabetes management strategies during pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.